Mersana Therapeutics Inc (MRSN) Live Share Price, Invest From India

Mersana Therapeutics Inc Stock Performance

as on January 6, 2026 at 7:59 am IST

Day's Low
Day's High
$28.90
Day's Price Range
$30.39
$29.10
0.69%
Downside
4.43%
Upside
52 Week's Low
52 Week's High
$5.21
52-Week Price Range
$30.39
$29.10
82.10%
Downside
4.43%
Upside

Mersana Therapeutics Inc share price movements today

Previous Close: $29.04
Open: $29.00
Volume: 858.6K
Day's Low - High: $28.90 - $30.39
52 Week Low - High: $5.21 - $30.39

Mersana Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Mersana Therapeutics Inc Stock Fundamentals & Key Indicators

Check Mersana Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Mersana Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mersana Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Mersana Therapeutics Inc	BUY	$-	NA	NA	0.00%
Insmed Incorporated	BUY	$32.0B	301.56%	-16.34	-210.54%
Alnylam Pharmaceuticals, Inc.	BUY	$40.9B	126.09%	131.65	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$113.9B	109.01%	29.32	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$78.4B	55.52%	17.89	31.41%

Analyst Recommendation on Mersana Therapeutics Inc Stock

Based on 15 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 15 analysts, 80% of analysts recommend a 'BUY' rating for Mersana Therapeutics Inc. Average target price of $33.2

Mersana Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Mersana Therapeutics Inc.

What analysts predicted

12.35%UPSIDE

Target Price

$33.2

Current Price

$29.1

Analyzed by

15 Analysts

Target

$33.20

Mersana Therapeutics Inc target price $33.2, a slight upside of 12.35% compared to current price of $29.1. According to 15 analysts rating.

Mersana Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	10	7	10	9	2	12	16	2	3	11
Gross Profit	10	7	10	9	2	12	16	2	2	11
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-54	-41	-19	-19	-24	-11	-14	-24	-24	-7
Net Profit Margin	-509.73%	-541.13%	-182.64%	-208.83%	-1058.35%	-91.29%	-86.28%	-875.93%	-795.03%	-68.53%

Mersana Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	10	25	17	10	42	0	0	26	36	40
Gross Profit	-10	-6	16	10	42	-66	0	26	36	40
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-16	-13	-38	-64	-28	-88	-170	-204	-171	-69
Net Profit Margin	-158.59%	-54.43%	-220.62%	-606.54%	-66.97%	-10633.45%	-395488.37%	-768.26%	-465.80%	-170.86%

Global Institutional Holdings in Mersana Therapeutics Inc

Funds	Holdings
State Street Corp	2.09%
Catalio Capital Management, LP	1.37%
683 Capital Management LLC	1.32%
Jacobs Levy Equity Management, Inc.	1.07%
IEQ CAPITAL, LLC	0.57%

See all

Mersana Therapeutics Inc News & Key Events

Insights on Mersana Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -24.29M → -7.54M (in $), with an average increase of 222.0% per quarter
POSITIVE IMPACT
Price Rise
In the last 3 months, MRSN stock has moved up by 265.3%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 2.75M → 11.00M (in $), with an average increase of 41.1% per quarter
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 165.0% return, outperforming this stock by 180.1%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 847.0% return, outperforming this stock by 926.0%

About Mersana Therapeutics Inc

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of antibody-drug conjugates (ADCs), which offer a clinically meaningful benefit for cancer patients with significant unmet needs. It has developed two proprietary and differentiated ADC platforms: Dolasynthen and Immunosynthen. Dolasynthen is a cytotoxic ADC platform that is designed to generate site-specific, homogeneous ADCs. Immunosynthen is its proprietary stimulator of interferon genes (STING)-agonist platform that is designed to generate systemically administered ADCs that locally activate STING signaling in both antigen-expressing tumor cells and in tumor-resident immune cells. The Company's pipeline includes Emi-Le (emiltatug ledadotin; XMT-1660), a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2).

Organisation	Mersana Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Mersana Therapeutics Inc share price today?

Mersana Therapeutics Inc share price today is $29.1 as on January 6, 2026 at 2:29 am IST at the close of the market. Mersana Therapeutics Inc share today touched a day high of $30.39 and a low of $28.9.

What is the 52 week high and 52 week low for Mersana Therapeutics Inc share?

Mersana Therapeutics Inc share touched a 52 week high of $30.39 on January 5, 2026 and a 52 week low of $5.21 on August 13, 2025. Mersana Therapeutics Inc stock price today i.e. January 6, 2026 at 2:29 am IST is closed at $29.1,which is 4.24% down from its 52 week high and 458.54% up from its 52 week low.

How to invest in Mersana Therapeutics Inc Stock (MRSN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mersana Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mersana Therapeutics Inc Shares that will get you 0.0515 shares as per Mersana Therapeutics Inc share price of $29.1 per share as on January 6, 2026 at 2:29 am IST.

What is the minimum amount required to buy Mersana Therapeutics Inc Stock (MRSN) from India?

Indian investors can start investing in Mersana Therapeutics Inc (MRSN) shares with as little as ₹94.138 or $1 (as of March 26, 2026 at 10:08 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹941.38 in Mersana Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 26, 2026 at 10:08 am IST). Based on Mersana Therapeutics Inc share’s latest price of $29.1 as on January 6, 2026 at 2:29 am IST, you will get 0.3436 shares of Mersana Therapeutics Inc. Learn more about fractional shares .